Cleared Traditional

K021024 - HEMOSIL HIGH ABNORMAL CONTROL ASSAYED (FDA 510(k) Clearance)

May 2002
Decision
48d
Days
Class 2
Risk

K021024 is an FDA 510(k) clearance for the HEMOSIL HIGH ABNORMAL CONTROL ASSAYED. This device is classified as a Plasma, Coagulation Control (Class II - Special Controls, product code GGN).

Submitted by Instrumentation Laboratory CO (Bedford, US). The FDA issued a Cleared decision on May 16, 2002, 48 days after receiving the submission on March 29, 2002.

This device falls under the Hematology FDA review panel. Regulated under 21 CFR 864.5425.

Submission Details

510(k) Number K021024 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 29, 2002
Decision Date May 16, 2002
Days to Decision 48 days
Submission Type Traditional
Review Panel Hematology (HE)
Summary Summary PDF

Device Classification

Product Code GGN — Plasma, Coagulation Control
Device Class Class II - Special Controls
CFR Regulation 21 CFR 864.5425